|
95
|
289
|
2aqxA |
Crystal structure of the catalytic and cam-binding domains of inositol 1,4,5-trisphosphate 3-kinase b |
|
171
|
519
|
2acxA |
Crystal structure of g protein coupled receptor kinase 6 bound to amppnp |
|
75
|
301
|
2ac5A |
Structure of human mnk2 kinase domain mutant d228g |
|
92
|
280
|
1zarA |
Crystal structure of a.fulgidus rio2 kinase complexed with adp and manganese ions |
|
86
|
300
|
2ac3A |
Structure of human mnk2 kinase domain |
|
82
|
273
|
2a19B |
Pkr kinase domain- eif2alpha- amp-pnp complex. |
|
104
|
348
|
1zyjA |
Human p38 map kinase in complex with inhibitor 1a |
|
82
|
278
|
1zwsA |
Crystal structure of the catalytic domain of human drp-1 kinase |
|
107
|
325
|
1zogA |
Crystal structure of protein kinase ck2 in complex with tbb-derivatives |
|
92
|
313
|
1zmuA |
Catalytic and ubiqutin-associated domains of mark2/par-1: wild type |
|
101
|
304
|
2a2aA |
High-resolution crystallographic analysis of the autoinhibited conformation of a human death-associated protein kinase |
|
107
|
351
|
1zzlA |
Crystal structure of p38 with triazolopyridine |
|
83
|
271
|
1zysA |
Co-crystal structure of checkpoint kinase chk1 with a pyrrolo-pyridine inhibitor |
|
103
|
325
|
1zoeA |
Crystal structure of protein kinase ck2 in complex with tbb-derivatives inhibitors |
|
92
|
303
|
1z9xA |
Human drp-1 kinase, w305s s308a d40 mutant, crystal form with 3 monomers in the asymmetric unit |
|
84
|
274
|
2a1aB |
Pkr kinase domain-eif2alpha complex |
|
82
|
275
|
1zltA |
Crystal structure of chk1 complexed with a hymenaldisine analog |
|
96
|
304
|
2a27A |
Human drp-1 kinase, w305s s308a d40 mutant, crystal form with 8 monomers in the asymmetric unit |
|
97
|
315
|
1zmwA |
Catalytic and ubiqutin-associated domains of mark2/par-1: t208a/s212a inactive double mutant |
|
71
|
298
|
2a4lA |
Human cyclin-dependent kinase 2 in complex with roscovitine |
|
75
|
302
|
1zydA |
Crystal structure of eif2alpha protein kinase gcn2: wild-type complexed with atp. |
|
83
|
302
|
1zy4A |
Crystal structure of eif2alpha protein kinase gcn2: r794g hyperactivating mutant in apo form. |
|
94
|
313
|
1zmvA |
Catalytic and ubiqutin-associated domains of mark2/par-1: k82r mutant |
|
76
|
301
|
1zxeA |
Crystal structure of eif2alpha protein kinase gcn2: d835n inactivating mutant in apo form |
|
80
|
259
|
2a98A |
Crystal structure of the catalytic domain of human inositol 1,4,5-trisphosphate 3-kinase c |
|
93
|
325
|
1zylA |
Crystal structure of hypothetical protein yihe from escherichia coli |
|
81
|
302
|
1zy5A |
Crystal structure of eif2alpha protein kinase gcn2: r794g hyperactivating mutant complexed with amppnp. |
|
111
|
326
|
1zohA |
Crystal structure of protein kinase ck2 in complex with tbb-derivatives inhibitors |
|
109
|
348
|
1zz2A |
Two classes of p38alpha map kinase inhibitors having a common diphenylether core but exhibiting divergent binding modes |
|
67
|
295
|
1zycA |
Crystal structure of eif2alpha protein kinase gcn2: wild-type in apo form. |
|
83
|
340
|
1zrzA |
Crystal structure of the catalytic domain of atypical protein kinase c-iota |
|
93
|
282
|
1zaoA |
Crystal structure of a.fulgidus rio2 kinase complexed with atp and manganese ions |
|
78
|
298
|
2a0cX |
Human cdk2 in complex with olomoucine ii, a novel 2,6,9-trisubstituted purine cyclin-dependent kinase inhibitor |
|
82
|
274
|
1yxxA |
Crystal structure of kinase pim1 in complex with (3e)-3-[(4-hydroxyphenyl)imino]-1h-indol-2(3h)-one |
|
100
|
348
|
1ywrA |
Crystal structure analysis of inactive p38 kinase domain in complex with a monocyclic pyrazolone inhibitor |
|
116
|
337
|
1z57A |
Crystal structure of human clk1 in complex with 10z-hymenialdisine |
|
83
|
273
|
1yxuA |
Crystal structure of kinase pim1 in complex with amp |
|
102
|
350
|
1yw2A |
Mutated mus musculus p38 kinase (mp38) |
|
81
|
274
|
1yxtA |
Crystal structure of kinase pim1 in complex with amppnp |
|
78
|
274
|
1ywvA |
Crystal structures of proto-oncogene kinase pim1: a target of aberrant somatic hypermutations in diffuse large cell lymphoma |
|
75
|
286
|
1z5mA |
Crystal structure of n1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl)amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2-dimethylpropanediamide complexed with human pdk1 |
|
80
|
274
|
1yxvA |
Crystal structure of kinase pim1 in complex with 3,4-dihydroxy-1-methylquinolin-2(1h)-one |
|
90
|
290
|
1yvjA |
Crystal structure of the jak3 kinase domain in complex with a staurosporine analogue |
|
79
|
274
|
1yxsA |
Crystal structure of kinase pim1 with p123m mutation |
|
92
|
302
|
1ywnA |
Vegfr2 in complex with a novel 4-amino-furo[2,3-d]pyrimidine |
|
79
|
278
|
1yolA |
Crystal structure of src kinase domain in complex with cgp77675 |
|
100
|
336
|
1ydtE |
Structure of camp-dependent protein kinase, alpha-catalytic subunit in complex with h89 protein kinase inhibitor n-[2-(4-bromocinnamylamino)ethyl]-5-isoquinoline |
|
85
|
315
|
1y8gA |
Catalytic and ubiqutin-associated domains of mark2/par-1: inactive double mutant with selenomethionine |
|
80
|
276
|
1yrpA |
Catalytic domain of human zip kinase phosphorylated at thr265 |
|
78
|
298
|
1ykrA |
Crystal structure of cdk2 with an aminoimidazo pyridine inhibitor |
